Clinuvel Pharmaceuticals Ltd (cuv) Logo

Clinuvel Pharmaceuticals Ltd (CUV)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

CUV ASX Chart

Snapshot

Clinuvel Pharmaceuticals Limited (CUV) is a global specialty pharmaceutical group focused on developing and commercialising treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for the general population.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -21.00%
vs ASX 200 (1yr) -31.50%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 378 of 2,382
Sector Rank 22 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies API / VRT / CU6
EPS $0.573
DPS $0.05
Book Value Per Share $3.281

Broker Consensus

CUV is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Latest Clinuvel Pharmaceuticals Ltd News

More News

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Melbourne VIC 3000
Website www.clinuvel.com
Registry Computershare
Auditor Grant Thornton
Date Listed 13 Feb 2001

Upcoming Calendar (Forecasted)

Date Event
27/08/2024 Report (Prelim)
27/08/2024 Report (Annual)
20/02/2025 Report (Interim)

Former Company Names

  • EpiTan Limited (EPT),28/02/2006

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
05/09/2023 $0.05 100% $0.0714 Final 20/09/2023
06/09/2022 $0.04 100% $0.0571 Final 21/09/2022
02/09/2021 $0.025 0% $0.025 Final 17/09/2021
02/09/2021 $0.025 0% $0.025 Interim 17/09/2021
03/09/2020 $0.025 0% $0.025 Final 18/09/2020
04/09/2019 $0.025 0% $0.025 Final 19/09/2019
21/09/2018 $0.02 0% $0.02 Final 08/10/2018

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.05
Gross DPS(TTM) $0.0714
Dividend yield
Gross yield
Payout Ratio 8%
DRP No
DRP Features --

Directors & Management

Directors

Management

Director Transactions

CUV directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
24/11/23 Philippe Wolgen Transfer 3,124,097 $17.00 $53,109,649 Off-market transfer
24/11/23 Philippe Wolgen Buy +301,125 $17.00 $5,119,125 Conversion of securities
24/11/23 Philippe Wolgen Exercise 301,125 $17.00 $5,119,125 Conversion of securities
24/11/23 Philippe Wolgen Expiry 1,212,625 $17.00 $20,614,625 As advised by the company
24/11/23 Philippe Wolgen Transfer 3,124,097 $17.00 $53,109,649 Off-market transfer
19/09/23 Philippe Wolgen Buy +1,850 $16.12 $29,813 On-market trade
26/06/23 Philippe Wolgen Transfer 3,120,715 $17.27 $53,894,748 Off-market transfer
26/06/23 Philippe Wolgen Transfer 3,120,715 $17.27 $53,894,748 Off-market transfer
26/06/23 Philippe Wolgen Buy +1,532 $17.72 $27,147 On-market trade
04/11/22 Jeffrey Rosenfeld Buy +300 $19.44 $5,832 On-market trade
16/06/22 Brenda Shanahan Sell +15,000 $14.04 ($210,535) On-market trade
07/06/22 Brenda Shanahan Sell +22,392 $15.88 ($355,606) On-market trade
10/05/22 Philippe Wolgen Buy +1,000 $16.14 $16,143 On-market trade
06/05/22 Andrew Likierman Buy +1,000 $9.07 $9,068 On-market trade
22/03/22 Philippe Wolgen Sell +55,606 $20.36 ($1,132,006) On-market trade
25/02/22 Jeffrey Rosenfeld Buy +485 $19.10 $9,263 On-market trade
14/01/22 Brenda Shanahan Expiry 25,000 $25.13 $628,250 As advised by the company
30/06/21 Philippe Wolgen Sell +122,675 $30.56 ($3,748,582) On-market trade
24/06/21 Brenda Shanahan Sell +25,000 $27.67 ($691,771) On-market trade
31/05/21 Philippe Wolgen Sell +102,700 $30.45 ($3,127,366) On-market trade
03/03/21 Philippe Wolgen Sell +104,000 $24.66 ($2,564,744) On-market trade
02/03/21 Jeffrey Rosenfeld Buy +670 $22.24 $14,898 On-market trade
10/09/20 Susan (Sue) Smith Buy +420 $21.40 $8,988 On-market trade
26/08/20 Philippe Wolgen Issued 1,513,750 $23.23 $35,164,412 Issue of securities
03/12/19 Jeffrey Rosenfeld Buy +1,093 $27.44 $29,988 On-market trade
02/12/19 Philippe Wolgen Issued 1,513,750 $26.87 $40,674,463 Issue of securities
04/11/19 Philippe Wolgen Buy +208,332 $31.12 $6,483,292 Conversion of securities
04/11/19 Philippe Wolgen Exercise 208,332 $31.12 $6,483,292 Conversion of securities
11/03/19 Brenda Shanahan Exercise 25,000 $26.90 $672,500 Conversion of securities
11/03/19 Philippe Wolgen Buy +716,642 $26.90 $19,277,670 Conversion of securities
11/03/19 Philippe Wolgen Exercise 716,642 $26.90 $19,277,670 Conversion of securities
11/03/19 Stanley McLiesh Buy +25,000 $26.90 $672,500 Conversion of securities
11/03/19 Stanley McLiesh Exercise 25,000 $26.90 $672,500 Conversion of securities
11/03/19 Brenda Shanahan Buy +25,000 $26.90 $672,500 Conversion of securities
02/07/18 Willem Blijdorp Buy +1,359,973 $10.00 $13,599,730 Off-market trade
03/08/16 Stanley McLiesh Buy +20,000 $4.98 $99,600 Conversion of securities
03/08/16 Brenda Shanahan Exercise 20,000 $4.98 $99,600 Conversion of securities
03/08/16 Brenda Shanahan Buy +20,000 $4.98 $99,600 Conversion of securities
03/08/16 Philippe Wolgen Exercise 499,890 $4.98 $2,489,452 Conversion of securities
03/08/16 Stanley McLiesh Exercise 20,000 $4.98 $99,600 Conversion of securities
03/08/16 Brenda Shanahan Exercise 80,000 $4.98 $398,400 Conversion of securities
03/08/16 Elie Ishag Exercise 14,000 $4.98 $69,720 Conversion of securities
03/08/16 Brenda Shanahan Buy +80,000 $4.98 $398,400 Conversion of securities
03/08/16 Philippe Wolgen Buy +499,890 $4.98 $2,489,452 Conversion of securities
03/08/16 Elie Ishag Buy +14,000 $4.98 $69,720 Conversion of securities
22/01/15 Stanley McLiesh Exercise 115,000 $3.85 $442,750 Conversion of securities
22/01/15 Stanley McLiesh Buy +115,000 $3.85 $442,750 Conversion of securities
22/01/15 Elie Ishag Exercise 63,500 $3.85 $244,475 Conversion of securities
22/01/15 Elie Ishag Buy +63,500 $3.85 $244,475 Conversion of securities
22/01/15 Philippe Wolgen Exercise 1,466,612 $3.85 $5,646,456 Conversion of securities
22/01/15 Philippe Wolgen Buy +1,466,612 $3.85 $5,646,456 Conversion of securities
22/12/14 Brenda Shanahan Issued 11,962 $4.18 $50,000 Placement
22/12/14 Philippe Wolgen Issued 35,866 $4.18 $150,000 Placement
22/12/14 Elie Ishag Issued 11,962 $4.18 $50,000 Placement
04/12/14 Brenda Shanahan Issued 100,000 $4.15 $415,000 Issue of securities
04/12/14 Elie Ishag Issued 70,000 $4.15 $290,500 Issue of securities
04/12/14 Stanley McLiesh Issued 120,000 $4.15 $498,000 Issue of securities
04/12/14 Philippe Wolgen Issued 2,499,810 $4.15 $10,374,212 Issue of securities
Show All

Director Interests

The current holdings of CUV directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Philippe Wolgen 24/11/2023 0 3,425,222 600,000 N/A
Jeffrey Rosenfeld 30/06/2023 N/A 3,148 N/A N/A
Karen Agersborg 30/06/2023 5,500 N/A N/A N/A
Susan (Sue) Smith 30/06/2023 420 N/A N/A N/A
Brenda Shanahan 30/06/2023 N/A 196,577 N/A N/A
Emilie Rodenburger N/A N/A N/A N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 15, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
HSBC Custody Nominees (Australia) Ltd 11,280,990 22.83%
BNP Paribas Nominees Pty Ltd Acf Clearstream 5,679,762 11.50%
BNP Paribas Nominees Pty Ltd 5,312,764 10.75%
J P Morgan Nominees Australia Pty Ltd 4,390,776 8.89%
Dr Philippe Jacques Wolgen 3,122,247 6.32%
Citicorp Nominees Pty Ltd 3,014,759 6.10%
Ender 1 LLC 2,590,824 5.24%
BNP Paribas Nominees Pty Ltd (ii) 1,482,356 3.00%
Emilino Group Pty Ltd 603,447 1.22%
National Nominees Ltd 548,371 1.11%
Dr Mark Edwin Badcock 440,085 0.89%
Mr David William Trevorrow 229,600 0.46%
Mr David John Lewis 187,000 0.38%
HSBC Custody Nominees (Australia) Ltd a/c 2 180,199 0.36%
Mr Trent Sheldon Redding 179,480 0.36%
Mr Darren Michael Keamy 178,588 0.36%
Rusty Hammer Pty Ltd 156,892 0.32%
Dr Dennis Wright 156,874 0.32%
Mr Simon John Bown 146,000 0.30%
BNP Paribas Noms (NZ) Ltd 130,710 0.26%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 4,381 951 152 163 25 5,672

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Ender 1, LLC and SNP Ventures Group Member 15/08/2023 2,340,824 6.13
Dr Philippe Jacques Wolgen 15/08/2023 3,122,247 6.73
JPMorgan Chase and Co and its affiliates 04/04/2024 2,643,991 5.27
The Bank of New York Mellon Corporation 29/01/2024 3,854,043 7.69

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
04-04-24 JPMorgan Chase and Co and its affiliates 2,643,991 -- 5.27
23-02-24 JPMorgan Chase and Co and its affiliates 2,570,363 -- 5.13

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
01-03-24 JPMorgan Chase and Co and its affiliates 2,570,363 5.13 --
29-01-24 The Bank of New York Mellon Corporation 442,429 8.70 7.69

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $17.88 30 June
2022 $14.85 30 June
2021 $30.70 30 June
2020 $25.65 30 June
2019 $33.68 28 June
2018 $11.01 29 June
2017 $6.98 28 June
2016 $4.32 28 June
2015 $2.84 30 June
2014 $1.70 30 June
CUV Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.